×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NAMS – newamsterdam pharma company n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NAMS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/11
06:14 am
nams
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Could Be 46% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Could Be 46% Below Their Intrinsic Value Estimate [Yahoo! Finance]
11/7
08:36 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Medium
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/6
08:00 am
nams
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
High
Report
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
11/1
05:26 pm
nams
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/28
04:30 pm
nams
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
Low
Report
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
10/4
04:30 pm
nams
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/23
08:53 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock.
9/7
08:42 am
nams
While institutions own 29% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), private equity firms are its largest shareholders with 47% ownership [Yahoo! Finance]
Low
Report
While institutions own 29% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), private equity firms are its largest shareholders with 47% ownership [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/6
08:01 am
nams
Form 10-Q NewAmsterdam Pharma Co For: Sep 30
High
Report
Form 10-Q NewAmsterdam Pharma Co For: Sep 30
11/6
08:00 am
nams
Form 8-K NewAmsterdam Pharma Co For: Nov 06
High
Report
Form 8-K NewAmsterdam Pharma Co For: Nov 06
10/28
08:03 am
nams
Form 20-F/A NewAmsterdam Pharma Co For: Dec 31
Medium
Report
Form 20-F/A NewAmsterdam Pharma Co For: Dec 31
10/18
04:52 pm
nams
Form 8-K NewAmsterdam Pharma Co For: Oct 18
Low
Report
Form 8-K NewAmsterdam Pharma Co For: Oct 18
10/11
05:01 pm
nams
Form 4 NewAmsterdam Pharma Co For: Oct 09 Filed by: Davidson Michael H.
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Oct 09 Filed by: Davidson Michael H.
10/1
05:24 pm
nams
Form 4 NewAmsterdam Pharma Co For: Sep 27 Filed by: Kooij Louise Frederika
Low
Report
Form 4 NewAmsterdam Pharma Co For: Sep 27 Filed by: Kooij Louise Frederika
10/1
05:12 pm
nams
Form 144 NewAmsterdam Pharma Co Filed by: Kooij Louise Frederika
Low
Report
Form 144 NewAmsterdam Pharma Co Filed by: Kooij Louise Frederika
9/30
05:23 pm
nams
Form 4 NewAmsterdam Pharma Co For: Sep 26 Filed by: Audet Juliette Berangere
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Sep 26 Filed by: Audet Juliette Berangere
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: